絞り込み

16314

広告

アジア各地に邦楽の公演可能なライブホール開設を発表

大手音楽会社のソニー・ミュージックエンタテインメントとそのグループ会社は、官民ファンドの支援を受けて、アジア各地に日本のアーティストなどが公演を行えるライブホー...

  1. ヒートショックプロテインを増やす入浴法 ...
  2. 痛風対策してますか?食事・運動・サプリメ...
  3. 英エコノミスト誌が予測「日本は人口減少で...
  4. 高浜原発4号機 燃料入れる作業始まる 来...

ニュース一覧

「vildagliptin」の検索結果

835件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Intraclass differences in the risk of hospitalisazion for heart failure among type 2 diabetic patients initiating a dipeptydil peptidase-4 inhibitor or a sulphonylurea. Results from the OsMed Health-DB registry.

Head to Head Comparison of Structurally Unrelated DPP4 Inhibitors in the Setting of Renal Ischemia Reperfusion Injury.

Effectiveness of Vildagliptin as add-on to Metformin Monotherapy among Uncontrolled Type 2 Diabetes Mellitus Patients in a Real-World Setting.

DPP-4 inhibitor treatment: β-cell response but not HbA1c reduction is dependent on the duration of diabetes.

CMD-05, a novel promising clinical anti-diabetic drug candidate, in vivo and vitro studies.

Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications.

Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in pre-diabetic rats.

Micro-Environmental Signature of The Interactions between Druggable Target Protein, Dipeptidyl Peptidase-IV, and Anti-Diabetic Drugs.

Cardiovascular safety of vildagliptin in patients with type 2 diabetes: a European multi-database, non-interventional post-authorization safety study.

Effectiveness and safety of vildagliptin and vildagliptin add-on to metformin in real-world settings in Egypt - results from the GUARD study.

DPP-4 Inhibitor and Estrogen Share Similar Efficacy Against Cardiac Ischemic-Reperfusion Injury in Obese-Insulin Resistant and Estrogen-Deprived Female Rats.

Bariatric surgery - time to replace with GLP-1?

Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.

Trigonelline and vildagliptin antidiabetic effect: improvement of insulin signalling pathway.

Profiling Proteinic Changes Induced by Vildagliptin Treatment in a Mouse Lung Transplantation Model: The Role of Kininogen-1.

Effects of 50 mg vildagliptin twice daily vs. 50 mg sitagliptin once daily on blood glucose fluctuations evaluated by long-term self-monitoring of blood glucose.

Effects of Vildagliptin and Metformin on Blood Pressure and Heart Rate Responses to Small Intestinal Glucose in Type 2 Diabetes.

Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: An experimental study.

Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.

Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります